Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know?

Gottlieb, Sami L; Berman, Stuart M; Low, Nicola (2010). Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know? Journal of infectious diseases, 201 Suppl 2, S156-S167. Cary, N.C.: The University of Chicago Press 10.1086/652396

	Text Gottlieb JInfectDis 2010.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (311kB)
Preview	Text 201-Supplement_2-S156.pdf - Other Available under License Publisher holds Copyright. Download (321kB) | Preview

Background. An important question for chlamydia control programs is the extent to which finding and treating prevalent, asymptomatic Chlamydia trachomatis genital infection reduces reproductive sequelae in infected women.

Methods. We reviewed the literature to critically evaluate evidence on the effect of chlamydia screening on development of sequelae in infected women.

Results. Two randomized controlled trials of 1-time screening for chlamydial infection—in a Seattle-area health maintenance organization and a Danish school district—revealed that screening was associated with an ∼50% reduction in the incidence of pelvic inflammatory disease over the following year. However, both of these trials had methodological issues that may have affected the magnitude of observed screening benefits and might limit generalizability to other populations. A large, nonrandomized cohort of chlamydia screening among US Army recruits, although limited by lack of outpatient data, did not find a benefit of similar magnitude to the randomized trials. Methodological limitations restrict valid conclusions about individual benefits of screening using data from historical cohorts and ecological studies. We identified no trials directly evaluating the effect of chlamydia screening on subclinical tubal inflammation or damage, ectopic pregnancy, or tubal factor infertility and no studies addressing the effects of >1 round of screening, the optimal frequency of screening, or the benefits of screening for repeat infections.

Conclusions. Additional studies of the effectiveness of chlamydia screening would be valuable; feasible study designs may depend on the degree to which screening programs are already established. In addition, better natural history data on the timing of tubal inflammation and damage after C. trachomatis infection and development of more accurate, noninvasive tools to assess chlamydial sequelae are essential to informing chlamydia control efforts.

Interest & Impact

Downloads

73 since deposited on 04 Oct 2013
6 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item